论文部分内容阅读
为了研究ASA间歇疗法对预防中风的可行性，阐明慢性胃炎患者抗幽门螺杆菌（HP）治疗的重要性。对131例HP相关性慢性胃炎和84例非HP相关性慢性胃炎病人的病理切片进行了分析比较、结果显示，NP相关性慢性胃炎病人的病理炎症程度较非HP相关性慢性胃炎病人的病理炎症程度要严重得多，且前者伴肠化和非典型增生明显多于后者，两者比较具有非常显著性差异，提示HP是慢性胃炎的重要病因之一。且与非典型增生乃至胃癌的友生密切相关。
In order to investigate the feasibility of ASA intermittent therapy in the prevention of stroke, the importance of anti-Helicobacter pylori (HP) therapy in patients with chronic gastritis was demonstrated. The pathological sections of 131 cases of HP-related chronic gastritis and 84 cases of non-HP-related chronic gastritis were analyzed and compared. The results showed that the pathological inflammatory degree of NP-related chronic gastritis patients was higher than that of non-HP-related chronic gastritis patients Degree is much more serious, and the former with intestinal metaplasia and atypical hyperplasia was significantly more than the latter, the two have very significant differences, suggesting that HP is one of the important causes of chronic gastritis. And with atypical hyperplasia and gastric cancer are closely related.